The efficacy of ferulic acid in the treatment of dementia (double-blinded study) - EFATD2

Shimane University0 个研究点目标入组 100 人开始时间: 2016年5月9日最近更新: 2023年10月17日

试验速览

阶段: 未知
状态: 已完成
发起方: Shimane University
入组人数: 100

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

This trial was done for mild cognitive impairment(MCI). There were not significant difference in MMSE, HDS-R, FAB(frontal assessment battery),hippocampal atrophy (MRI VSRAD) and ADAS-cog between ferulic acid group(n=37) and placebo group(n=41) for one year.

研究设计

研究类型: Interventional

入排标准

年龄范围: 65years-old 至 89years-old（—）
性别: All

入选标准

未提供

排除标准

•metabolic encephalopathy(hypothyroidism),head trauma,malignancy,alcohl abuse, mental disorder,chronic renal failure, chronic heart failure,chronic liver injury and patients treated by major tranquilizer.

研究者

发起方

Shimane University

相似试验

已完成

不适用

The efficacy of ferulic acid in the treatment of dementia

JPRN-UMIN000003683Shimane University Hospital50

已完成

3 期

Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney DiseaseRenal Insufficiency, ChronicIron-Deficiency Anemia

NCT02968368Shield Therapeutics167

Unknown

2 期

Folinic Acid in Children With Autism Spectrum DisordersAutism Spectrum Disorder

NCT02551380Central Hospital, Nancy, France40

已完成

3 期

EFFICACY OF RUESI DADTON ON MILD COGNITIVE IMPAIRMENT: A RANDOMIZED CONTROL TRIAmild cognitive impairmentelderlymild cognitive impairmentelderlyThai exerciseRuesi DadtonBDNFirisinoxidative stressmind body medicine

TCTR20200727001-71

已完成

3 期

Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBDAnemia, Iron-DeficiencyCrohn's DiseaseInflammatory Bowel Disease

NCT02680756Shield Therapeutics250